HOME >> BIOLOGY >> NEWS
A dream team tackles the brain

Researchers combine expertise in physics, engineering, and biology to develop a new tool to study brain synapses

(Boston, Mass.) - Thanks to a recent grant of nearly $1 million from the David and Lucille Packard Foundation, three Boston University scientists will apply advanced theories in quantum physics to observe what occurs at brain synapses - the sites of communication between neurons. The ability to make these observations could ultimately lead to a better understanding of how the brain functions.

Kristen Harris, professor of biology, working with Bahaa Saleh, professor and chair of electrical and computer engineering, and Malvin Teich, professor of engineering and physics, will use the grant over the next five years to develop a potentially revolutionary new form of microscopy, called entangled-photon fluorescence microscopy, and apply it to unraveling crucial issues in neuroscience.

Harris has devoted her career to the study of dendritic spines, the tiny protrusions that stud the surface of neurons and that have excitatory synapses on them.

"The new imaging technology that we are developing holds the promise of unraveling the century-old question of how these spines function," she states. "We know that they are crucial to cognitive processes such as learning and memory, but we know little about how they work, primarily because they are so small that they challenge existing optical imaging techniques needed to visualize living spines."

The new imaging technique being developed utilizes a non-classical light source - a weak beam of photon pairs generated by passing laser light through a nonlinear optical crystal. The entangled-photon pairs are expected to provide better resolution and a significant reduction in light-induced tissue damage - allowing scientists to examine functioning living tissue over time without destroying it.

The David an
'"/>

Contact: Joan Schwartz
joschwar@bu.edu
617-353-4626
Boston University
1-Sep-1999


Page: 1 2

Related biology news :

1. Therapeutic cloning no longer a dream, says scientist who produced first cloned embryonic stem cell
2. "All my friends dream of artificial limbs": US, Russian nuclear labs work with prosthetics company to develop replacement knee
3. Evo-devo biology tackles evolutionary historys unanswered questions
4. Software tackles protein pathways
5. Trial shows which brain cancer patients benefit from temozolomide
6. Targeted therapy knocks out pediatric brain cancer in mice
7. New way to protect brain from stroke damage
8. Chemical signals health of brain cells Symposium
9. DHA-rich diet protects brain from Alzheimers damage, UCLA study shows
10. Decreasing toxins in brains of Alzheimers patients keep cognitive deficits at bay
11. Genetic clues found for common congenital brain disorder

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: dream team tackles the brain

(Date:5/21/2013)... at Chicago College of Medicine will study gender differences in ... energy source -- and how changes in fat metabolism play ... 4-year grant from the National Heart, Lung and Blood Institute. ... for energy. These changes may play a major role in ... and women, says E. Douglas Lewandowski, director of the UIC ...
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
(Date:5/20/2013)... is known about the effect of physical education (PE) ... University finds that increasing the amount of time that ... of obesity. , The study represents some of the ... youth obesity, and is forthcoming in the Journal ... of the study can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3Gym class reduces probability of obesity, study finds for first time 2
(Date:5/21/2013)... May 21, 2013 Alpha Source, ... , will be exhibiting for the 13th consecutive ... Medical Instrumentation (AAMI) 2013 Conference and Expo. The ... distribute, and manufacture healthcare technologies. This year’s event ... Beach, California. , The three-day event draws ...
(Date:5/21/2013)... Raleigh, NC (PRWEB) May 21, 2013 ... and financial services company for clinical trials, announced ... Aggregate Spend Solutions, LLC. Clinverse’s ClinPay® FLS ... automated investigator payment process. SpendMD ™, ... only complete solution for tracking and reporting transfer ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 As ... a strong push within the industry to deliver ... Manufacturing Organizations and pharma companies often means turning ... , Microtablets, developed in collaboration with Sensidose AB ... outsourcing can bring products to market sooner. The ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: